Results: Ten days after initiation of moxifloxacin, the patient developed synchronous DILI and TEN, suggesting that prior immunotherapy may have lowered the threshold for immune tolerance and amplified T cellmediated, drug-induced immune responses
Benzodiazepines and Other Central Nervous System (CNS) Depressants Due to additive pharmacologic effect, the concomitant use of benzodiazepines and other CNS depressants, such as benzodiazepines and other sedative hypnotics, anxiolytics, and tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), and other opioids, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes
A planned Phase I safety trial of 42 healthy volunteers receiving oral BPC-157 was conducted in 2015, but results were never formally published following cancellation of planned submission in 2016
